The Cox-Maze Procedure for Atrial Fibrillation Concomitant with Mitral Valve Disease

승모판막질환에 동반된 심방세동에서 Cox-Maze 술식

  • Kim, Ki-Bong (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Seoul National University) ;
  • Cho, Kwang-Ree (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Seoul National University) ;
  • Ahn, Hyuk (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Seoul National University)
  • 김기봉 (서울대학교 의과대학 흉부외과학 교실) ;
  • 조광리 (서울대학교 의과대학 흉부외과학 교실) ;
  • 안혁 (서울대학교 의과대학 흉부외과학 교실)
  • Published : 1998.10.01

Abstract

Background: The sugical results of the Cox-Maze procedure (CMP) for lone atrial fibrillation(AF) have proven to be exellent. However, those for AF associated with mitral valve(MV) disease have been reported to be a little inferior. Materials and methods: To assess the efficacy and safety of the CMP as a combined procedure with MV operation, we studied retrospectively our experiences. Between April 1994 and October 1997, we experienced 70 (23 males, 47 females) cases of CMP concomitantly with MV operation. Results: The etiologies of MV disease were rheumatic in 67 and degenerative in 3 cases. The mean duration of AF before sugery was 66$\pm$70 months. Fifteen patients had the past medical history of thromboembolic complications, and left atrial thrombi were identified at operation in 24 patients. Twelve cases were reoperations. Aortic cross clamp (ACC) time was mean 151$\pm$44 minutes, and cardiopulmonary bypass (CPB) time was mean 246$\pm$65 minutes. Concomitant procedures were mitral valve replacement (MVR) in 19, MVR and aortic valve replacement (AVR) in 14, MVR and tricupid annuloplasty (TAP) in 8, MVR with AV repair in 3, MV repair in 11, MVR and coronary artery bypass grafting (CABG) in 2, MVR and AVR and CABG in 1, redo-MVR in 10, redo-MVR and redo-AVR in 2 patients. The rate of hospital mortality was 1.4%(1/70). Perioperative recurrence of AF was seen in 44(62.9%), and atrial tachyarrhythmias in 10(14.3%), low cardiac output syndrome in 4(5.7%), postoperative bleeding that required mediastinal exploration in 4(5.7%) patients. Other complications were acute renal failure in 2, aggravation of preoperative hemiplegia in 1, and transient delirium in 1 patient. We followed up all the survivors for 16.4 months(3-44months) on an average. Sinus rhythm has been restored in 65(94.2%) patients. AF has been controlled by operation alone in 73.9% and operation plus medication in 20.3%. Two patients needed permanent pacemaker implantation; one with sick sinus syndrome, and the other with tachycardia- bradycardia syndrome. Only two patients remained in AF. We followed up our patients with transthoracic echocardiography to assess the atrial contractilities and other cardiac functions. Right atrial contractility could be demonstrated in 92% and left atrial contractility in 53%.We compared our non-redo cases with redo cases. Although the duration of AF was significantly longer in redo cases, there was no differences in ACC time, CPB time, postoperative bleeding amount and sinus conversion rate. Conclusions: In conclusion, the CMP concomitant with MV operation demonstrated a high sinus conversion rate under the acceptable operative risk even in case of reoperation.

연구배경 : 심장의 구조적 이상을 동반하지 않는 만성 심방세동에 대한 Cox-Maze 술식의 성적은 매우 좋은 것으로 보고되고 있으나 승모판막 질환과 같은 기질적 심장질환에 동반된 심방세동에서의 성적은 다소 떨어지는 것으로 보고되고 있다. 대상 및 방법 : 본 서울대학교병원 흉부외과학 교실에서는 승모판막 질환에 대한 수술과 함깨 시행한 Cox-Maze 술식의 효과와 안전성을 평가하기위해 1994년 4월부터 1997년 10월까지 경험한 70례(남;23, 여;47)를 대상으로 임상 연구를 하였다. 결과 : 70례중 67례가 류마티스성 승모판막 질환이었으며 3례가 퇴행성 질환이었다. 술전 심방세동의 평균 유병기간은 66$\pm$70개월이었다. 15명의 환자에서 과거력상 혈전색전증의 병력이 있었으며 24명의 환자에서 수술중 좌심방내의 혈전이 존재하였다. 과거에 조직판막을 이용한 판막치환술의 병력이 있었던 재수술례가 12례였다. 수술시 대동맥차단시간은 평균 151$\pm$44분이었으며 심폐우회시간은 평균 246$\pm$65분이었다. Cox-Maze 술식과 함께 시행한 수술로는 승모판막 치환술이 19례,승모판막과 대동맥판막 치환술이 14례, 승모판막 치환술과 삼첨판막륜 성형술이 8례, 승모판막 치환술 및 대동맥판막 성형술이 3례있었으며 11례에서는 승모판막 성형술이 가능하였다. 판막치환술과 관상동맥우회술을 같이 시행한 례가 3례있었으며 승모판막 재치환술이 10례, 승모판막 및 대동맥 판막 재치환술이 2례 있었다. 수술사망률은 1.4%(1/70)였다. 수술후 합병증으로는 술후 일시적 심방세동의 재발을 보인 례가 44례였으며 상심실성 빈맥이 10례, 저심박출증후군이 4례, 출혈에 의한 재수술이 4례있었다. 그 밖의 합병증으로는 급성 신부전이 1례, 수술전의 일측 편마비가 악화된 경우가 1례, 그리고 일시적 섬망이 1례 있었다. 생존한 모든 환자를 평균 16.4개월간 외래를 통한 추적관찰하였는데 동기능부전 증후군과 빈맥-서맥 증후군을 보인 2명의 환자에서 영구형 심박동기의 삽입이 필요하였고, 2례만이 현재 심방세동을 보이고 있어서 동율동으로의 전환율은 94.2%였다. 수술만으로 심방세동이 조절되었던 경우가 73.9% 이었고, 수술후 항부정맥제의 병행 투약이 필요했던 경우가 20.3% 이었다. 술후 심방수축력과 기타 심기능의 평가를 위하여 시행한 경흉부 심초음파 검사 소견상 우심방 수축력은 92%에서, 좌심방 수축력의 회복은 53%에서 관찰되었다. 판막재치환술을 시행한 환자들을 첫 수술인 환자들과 비교하였을 때, 심방세동의 유병기간은 재수술한 례에서 통계적으로 유의하게 길었으나 대동맥차단시간, 심폐우회시간, 수술당일의 출혈량, 동율동으로의 전환율등에서는 차이가 없었다. 결론 : 결론적으로 승모판막 질환에 대한 수술과 함께 시행한 Cox-Maze 술식은 비교적 낮은 수술위험도 하에서 높은 동율동 전환률을 보였으며 특히 재수술시에도 비교적 안전하며 매우 효과적이었다.

Keywords

References

  1. J Thorac Cardiovasc Surg v.101 The surgical treatment of atrial fibrillation. Ⅳ. Surgical technique Cox JL
  2. J Thorac Cardiovasc Surg v.108 Cox maze procedure for chronic atrial frbrillation associated with mitral valve disease Kosakai Y;Kawaguchi AT;Isobe F(et al.)
  3. Circualtion v.93 Management of patients with atrial fibrillation: A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology Prystowsky EN;Benson DW;Fuster V(et al.)
  4. J Thorac Cardiovasc Surg v.101 The surgical treatment of atrial fibrillation Ⅰ. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation Cox JL;Schuessler RB;Boineau JP
  5. J Thorac Cardiovasc Surg v.101 The surgical treatment of atrial fibrillation Ⅱ. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation Cox JL;Canavan TE;Schuessler RB(et al.)
  6. Ann Thorac Surg v.55 Evolving applications of the maze procedure for atrial fibrillation Cox JL
  7. Ann Thorac Surg v.56 Five-year experience with the maze procedure for atrial fibrillation Cox JL;Boineau JP;Schuessler RB(et al.)
  8. Ann Thorac Surg v.58 From fisherman to fibrillation: An unbroken line of progress Cox JL;Boineau JP;Schuessler RB(et al.)
  9. J Thorac Cardiovasc Surg v.110 Modification of the maze procedure for atrial flutter and atrial fibrillation. Ⅰ. Rationale and surgical results Cox JL;Boineau JP;Schuessler RB(et al.)
  10. J Thorac Cardiovasc Surg v.110 Modification of the maze procedure for atrial flutter and atrial fibrillation.Ⅱ. Surgical technique of the maze Ⅲ procedure Cox JL;Jaquiss RD;Schuessler BR(et al.)
  11. Heart v.77 Electrocardiographic nature of restored sinus rhythm after Cox maze procedure in patients with chronic atrial frbrillation who also had other cardiac surgery Kamata J;Nakai K;Chiba N(et al.)
  12. 대흉외지 승모판막질환을 동반하지않은 심방세동에서의 Cox-Maze 술식-3례 보고- 강창현;김기봉
  13. 대흉외지 v.30 심방세동의 수술요법 김기봉;이창하;손대원;노준량
  14. Ann Thorac Surg v.64 Predictors of sinus rhythm restoration after Cox maze procedure concomitant with other cardiac operations Kamata J;Kawazoe K;Izumoto H(et al.)
  15. J Heart Valve Dis v.6 Can the maze procedure ge combined safety with mitral valve repair? Izumoto H;Kawazow K;Kitahara H(et al.)
  16. J Thorac Cardiovasc Surg v.105 Initial experience with the maze procedure for atrial fibrillation McCarthy PM;Castle LW;Maloney JD(et al.)
  17. Ann Thorac Surg v.60 Left atrial function after Cox's maze operation concomitant with mitral valve operation Itoh T;Okamoto H;Nimi T(et al.)
  18. Circulation v.90 Restoration of atrial function after the maze procedure for patients with atrial fibrillation Feinberg MS;Waggoner AD;Kater KM(et al.)
  19. Eur Heart J v.18 Serial evaluation of atrial function by doppler echocardiography after the maze procedure for chronic atrial fibrillation Yashima N;Nasu M;Kawazoe K;Hiramori K